7th Annual MSK Symposium on Lymphoma

Dr. Gilles Salles welcomes you to the 7th Annual MSK Symposium on Lymphoma.

We are excited to welcome attendees back to New York City for the 7th Annual MSK Symposium on Lymphoma. This Symposium will feature updated information on lymphoma biology, diagnosis, and ongoing efforts to translate scientific discoveries into novel treatment strategies for a variety of lymphoma subtypes.

This year, we will address the clinical management of the most frequent lymphoma entities and will feature focused sessions related to new families of drugs being developed in these areas as well as in less common presentations. Faculty will present those and then discuss, during a panel, how to best approach patients’ situations. We will also cover, in a special session, recent advances in the biology of lymphoma and how these will translate to innovative therapeutic interventions

Highlights of this year's hybrid program include:

FRIDAY, MAY 5

Afternoon Breakout Sessions - Two concurrent breakout sessions will be held on Friday afternoon. Selection for the breakout sessions must be made during your registration. Options include:

• Science in Progress (In-person or Virtual)
• Nursing Professional Development (In-person Only) - Space is very limited for this breakout. We encourage early registration and ask registrants to ONLY make this selection if you are confirmed to participate in the session in its entirety.

Networking Reception (In-person Only) - In-person attendees are invited to join the Symposium faculty for a networking reception on Friday evening. This event will be held in the lobby of Zuckerman Research Center and RSVP is required. If you are interested in joining the reception, please be sure to select this as an option in your registration. Hors d'oeuvre and refreshments will be served.

SATURDAY, MAY 6

Breakfast Symposium: Chronic Lymphocytic Leukemia (In-person Only) - A special breakfast symposium will be held for in-person attendees on Saturday morning. Space is limited; we ask registrants to ONLY make this selection at registration if you are confirmed to participate. 

Luncheon Session: What's new in Multiple Myeloma (In-person Only) - A special luncheon session will be held at the end of the program on Saturday for in-person attendees. Space is limited for this session; we ask registrants to ONLY make this selection at registration if you are confirmed to participate.

Online Syllabus

Registered attendees will receive access to an online syllabus after the course, which includes select PDFs of the faculty presentations (slides) and recorded videos from the course. MSK CME will email attendees when this becomes available. Attendees must check-in on the day of the Symposium in order to receive access to the syllabus.

Please note that the Nursing Professional Development breakout session, the Breakfast Symposium on Chronic Lymphocytic Leukemia, and the Luncheon Session on Multiple Myeloma will be recorded and made available on the syllabus after the Symposium to all attendees. 

Who Should Attend

The target audience for this Symposium includes internists, oncologists, hematologists as well as medical and radiation oncologists, hematopathologists, scientists, and medical trainees involved in the diagnosis, treatment, and biomedical research of lymphoma.

1. Describe recent refinements in lymphoma classification
2. Discuss first line treatment options in most frequent lymphoma entities
3. Describe new agents mode of actions, efficacy, side effects
4. Discuss options and recommendations for patients in the relapse refractory setting
5. Provide adequate information to help shared decision with patients regarding their treatment

Registration Fees (In-person or Virtual)

• Physicians (MDs, PhDs, PharmDs, and DOs)
  • Early Rate: $375
  • General Rate: $450
• Advanced Practice Providers
  • Early Rate: $125
  • General Rate: $200
• Nurses and Other Healthcare Providers
  • Early Rate: $75
  • General Rate: $150
• Residents and Fellows
  • Early Rate: $25 (non-refundable)
  • General Rate: $100
• Industry Professionals*
  • Early Rate: n/a
  • General Rate: $785
• MSK Employees
  • Complimentary

*Industry professionals may attend MSK CME activities for their own education. Marketing, sales, and promotion of products and services is strictly prohibited at MSK CME activities. For more information, please visit our Help page.

Registration Discounts/Promotions

• EARLY RATE: Register by 11:59 pm EST on March 31, 2023 to receive a $75 off your total registration. Enter the promotion code EARLYM23 during registration to take advantage of the early rate discount.
• A registration discount is available for MSK Alumni and MSK Cancer Alliance members to attend this Symposium. If you are a member of one of these groups, contact [email protected] for details.

Please note that after your payment has been processed, no further promotional discounts or adjustments will be made to your registration.

In-person Registration

Course registration includes continental breakfast, lunch, refreshment breaks, and an invitation to the networking reception on Friday evening. Please contact [email protected] at least one week prior to the course if you have any special dietary requests or require any specific accommodations.

While MSK requests that institutional guests are vaccinated against COVID-19, we are no longer requiring proof of vaccination. Additional details, including our current Health and Safety Protocols, can be accessed on our Visiting Us page. If you are not feeling well or exhibiting any symptoms of COVID-19, please refrain from attending an in-person event at MSK and contact [email protected] as soon as possible.

Virtual Registration

The virtual option for this program will be delivered through Zoom. Access details, including a link to Zoom and faculty disclosures, will be sent to virtual registrants via email prior to the start of the Symposium.

Cancellation Policy

If you wish to cancel your participation in this course, you must email [email protected] at least seven (7) days prior to the start of the course, and your refund will be subject to a $25 administrative fee if attending virtually or a $100 administrative fee if attending in-person. Cancellations or no-shows within seven (7) days of the course are not eligible for a refund. Please note that if it has been more than 120 days since payment was processed, a W9 form must be submitted in order process your refund and your refund will be issued in the form of a check payment. Refunds are not subject to tax. You may substitute another registrant in your place at any time by contacting [email protected] with the appropriate information.

MSK CME reserves the right to cancel or postpone any course due to unforeseen circumstances. In the unlikely event we must cancel or postpone this course, you will be notified via email from MSK CME ([email protected]). A full refund will be issued for your registration. MSK CME is not responsible for any related costs, charges, or expenses to participants, including fees incurred by airline/travel/lodging agencies.

Please note that the residents and fellows early rate is non-refundable.

Memorial Sloan Kettering Cancer Center is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

AMA Credit Designation Statement

Memorial Sloan Kettering Cancer Center designates this live activity for a maximum of 12.75 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

ABIM MOC Recognition Statement

Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 12.75 Medical Knowledge MOC points in the American Board of Internal Medicine’s (ABIM) Maintenance of Certification (MOC) program. Participants will earn MOC points equivalent to the amount of CME credits claimed for the activity. It is the CME activity provider’s responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit.

NCPD Contact Hours: Pending

MSK Symposium Director 

Gilles Salles, MD, PhD
Chief, Lymphoma Service

MSK Planning Committee

Annalisa Benz, BSN, RN, OCN 
Nurse Planner

Ahmet Dogan, MD, PhD
Chief, Hematopathology Service

Kojo Elenitoba-Johnson, MD
Chairman, Department of Pathology 

Steven Horwitz, MD
Attending, Lymphoma Service

Andrew Intlekofer, MD
Assistant Attending, Lymphoma Service

Ariela Noy, MD
Attending, Lymphoma Service

Robert Stuver, MD
Hematology/Oncology Fellow

Hans-Guido Wendel, MD
Member/Professor, Cancer Biology and Genetics Program

Joachim Yahalom, MD, FACR, FASTRO
Attending, External Beam Radiotherapy Service

Andrew D. Zelenetz, MD, PhD 
Medical Director, Quality Informatics
Attending, Lymphoma Service 

Invited Faculty 

Ranjana Advani, MD
Saul Rosenberg Professor of Lymphoma
Stanford University
Stanford, CA

Philippe Armand, MD, PHD
Professor of Medicine
Dana-Farber Cancer Institute
Boston, MA

Nancy Bartlett, MD
Koman Professor of Medical Oncology
Washington University School of Medicine
St. Louis, MD

Wendy Beguelin, PhD
Assistant Professor of Pharmacology in Medicine
Weill Cornell Medicine
New York, NY

Michael Dickinson, MBBS
Haematologist and Disease Group Lead: Aggressive Lymphoma 
Peter MacCallum Cancer Centre
Melbourne, Australia 

Alex Herrera, MD
Assoicate Professor/Hematologist-Oncologist
City of Hope
Duarte, CA

Caron Jacobson, MD
Assistant Professor, Medicine, Harvard Medical School
Medical Director, Immune Engineered Cell Therapy Program, Medical Oncology
Dana-Farber Cancer Institute
Boston, MA

Michael Khodadoust, MD, PHD
Assistant Professor 
Stanford University
Stanford, CA

Matthew Maurer, MS, DMSc
Assistant Professor of Biostatistics and Medicine
Mayo Clinic
Rochester, MN

Neha Mehta-Shah, MD, MSCI
Associate Professor
Washington University School of Medicine
St. Louis, MD

Lindsay Morton, PhD
Senior Investigator; 
Director, Radiation Epidemiology Branch; 
Head, Cancer Survivorship Research Unit
National Cancer Institute
Bethesda, MD

Loretta Nastoupil, MD
Associate Professor
MD Anderson Cancer Center
Houston, TX

Louis Staudt, MD, PHD
Director, Center for Cancer Genomics
National Institute of Health
Bethesda, MD

Michael Williams, MD
Byrd S. Leavell Professor of Medicine; Division Chief, Medicine: 
Hematology and Oncology
University of Virginia
Charlottesville, VA

MSK Faculty 

Omar Abdel-Wahab, MD
Chair, SKI Molecular Pharmacology Program

Kevin David, MD
Associate Attending, Lymphoma Service

Paola Ghione, MD
Assistant Attending, Lymphoma Service

Brandon Imber, MD, MA
Assistant Attending, Department of Radiation Oncology

Neha S. Korde, MD
Associate Attending, Myeloma Service

Anita Kumar, MD
Assistant Attending, Lymphoma Service

Megan So-Young Lim, MD, PhD
Attending, Department of Pathology

Jennifer K. Lue, MD
Assistant Attending, Lymphoma Service

Alison J. Moskowitz, MD
Associate Attending, Lymphoma Service

M. Lia Palomba, MD
Member, Lymphoma and Cellular Therapeutics Services

Gunjan L. Shah, MD, MS
Assistant Attending, Bone Marrow Transplant and Cellular Therapy Services

Meghan Thompson, MD
Assistant Attending, Leukemia Service

Pallawi Torka, MD
Assistant Attending, Lymphoma Service

Saad Z. Usmani, MD, MBA, FACP
Chief, Myeloma Service

Santosha Vardhana, MD, PhD
Assistant Member, Human Oncology and Pathogenesis Program
Assistant Attending, Lymphoma Service

Mitigation of Relevant Financial Relationships

Memorial Sloan Kettering Cancer Center adheres to the ACCME’s Standards for Integrity and Independence in Accredited Continuing Education. Any individuals in a position to control the content of a CE activity, including faculty, planners, reviewers, or others are required to disclose all financial relationships with ineligible companies (commercial interests). All relevant financial relationships have been mitigated prior to the commencement of the activity.

Memorial Sloan Kettering gratefully acknowledges the following organizations for providing educational grants for this live activity:

AstraZeneca
Novartis